Garima Mittal1, Pratima Gupta1, Bhaskar Thakuria2, Gulshan K Mukhiya3, Manish Mittal4. 1. Department of Microbiology, Himalayan Institute of Medical Sciences, Jolly Grant, Dehradun, India. 2. Department of Microbiology, Shubharti Medical College, Meerut, India. 3. Department of Nephrology, Apollo Hospital, Dhaka, Bangladesh, India. 4. Department of Neurology, Himalayan Institute of Medical Sciences, Jolly Grant, Dehradun, India.
Abstract
BACKGROUND AND AIM: Viral hepatitis and human immunodeficiency virus (HIV) infection are important causes of morbidity and mortality in hemodialysis (HD) patients. The present study was performed to assess the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV) and HIV infections in hemodialysis patients of a tertiary care hospital in Uttarakhand. METHODS: All patients undergoing maintenance HD at our center were screened for hepatitis B surface antigen (HBsAg), antibody to HCV (anti-HCV), antibody to HDV (anti-HDV) and HIV antibody by ELISA. Detailed history regarding age, sex, duration of dialysis, blood transfusions, number of dialysis centers, dialyzer reuse and laboratory data was recorded. RESULTS: A total of 118 patients (79 males and 39 females) were followed for 18 months with screening for the presence of HBV, HCV and HIV infections. At baseline, 12 (10.2%) patients were positive for HBsAg, 19 (16.1%) for anti-HCV and 2 (1.7%) for HIV antibody. Over 18 months, one additional patient became HBsAg positive and an additional 17 became anti-HCV-positive to give a total of 36 HCV-positive patients. Dual HBV and HCV infection was seen in 5 (4.2%) and anti-HDV antibodies were found in 1 (0.9%) patient. History of blood transfusions, duration of HD, dialyzer reuse and dialysis at multiple centers were found to be important risk factors for anti-HCV positivity. CONCLUSIONS: Implementation and adherence to universal work precautions by dialysis staff is imperative to prevent transmission of these infections.
BACKGROUND AND AIM: Viral hepatitis and human immunodeficiency virus (HIV) infection are important causes of morbidity and mortality in hemodialysis (HD) patients. The present study was performed to assess the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV) and HIV infections in hemodialysis patients of a tertiary care hospital in Uttarakhand. METHODS: All patients undergoing maintenance HD at our center were screened for hepatitis B surface antigen (HBsAg), antibody to HCV (anti-HCV), antibody to HDV (anti-HDV) and HIV antibody by ELISA. Detailed history regarding age, sex, duration of dialysis, blood transfusions, number of dialysis centers, dialyzer reuse and laboratory data was recorded. RESULTS: A total of 118 patients (79 males and 39 females) were followed for 18 months with screening for the presence of HBV, HCV and HIV infections. At baseline, 12 (10.2%) patients were positive for HBsAg, 19 (16.1%) for anti-HCV and 2 (1.7%) for HIV antibody. Over 18 months, one additional patient became HBsAg positive and an additional 17 became anti-HCV-positive to give a total of 36 HCV-positive patients. Dual HBV and HCV infection was seen in 5 (4.2%) and anti-HDV antibodies were found in 1 (0.9%) patient. History of blood transfusions, duration of HD, dialyzer reuse and dialysis at multiple centers were found to be important risk factors for anti-HCV positivity. CONCLUSIONS: Implementation and adherence to universal work precautions by dialysis staff is imperative to prevent transmission of these infections.
Entities:
Keywords:
ESRD, end-stage renal disease; HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; HD, haemodialysis; HDV, hepatitis D virus; HIV; HIV, human immunodeficiency virus; hemodialysis; hepatitis B; hepatitis C; hepatitis D
Authors: O Alfurayh; A Sabeel; M N Al Ahdal; K Almeshari; G Kessie; M Hamid; D M Dela Cruz Journal: Am J Nephrol Date: 2000 Mar-Apr Impact factor: 3.754
Authors: Rachel B Fissell; Jennifer L Bragg-Gresham; John D Woods; Michel Jadoul; Brenda Gillespie; Sara A Hedderwick; Hugh C Rayner; Roger N Greenwood; Takashi Akiba; Eric W Young Journal: Kidney Int Date: 2004-06 Impact factor: 10.612
Authors: C Oesterreicher; J Hammer; U Koch; F Pfeffel; G Sunder-Plassmann; D Petermann; C Müller Journal: Kidney Int Date: 1995-12 Impact factor: 10.612
Authors: F H Pujol; J G Ponce; M G Lema; F Capriles; M Devesa; F Sirit; M Salazar; G Vásquez; F Monsalve; L Blitz-Dorfman Journal: J Clin Microbiol Date: 1996-07 Impact factor: 5.948
Authors: Karla P Souza; Jônio A Luz; Sheila A Teles; Megmar A S Carneiro; Luciana A Oliveira; Adriane S Gomes; Márcia A Dias; Selma A Gomes; Clara F T Yoshida; Regina M B Martins Journal: Mem Inst Oswaldo Cruz Date: 2003-07 Impact factor: 2.743
Authors: M Cendoroglo Neto; S A Draibe; A E Silva; M L Ferraz; C Granato; C A Pereira; R C Sesso; A M Gaspar; H Ajzen Journal: Nephrol Dial Transplant Date: 1995 Impact factor: 5.992
Authors: Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Radha K Dhiman; Rakesh Aggarwal; Shivram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoorz; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Shiv K Sarin; Samir Shah; P K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan Journal: J Clin Exp Hepatol Date: 2014-06-09
Authors: Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K K Lau; Barjesh C Sharma; Saeed S Hamid; Wan-Long Chuang; A Kadir Dokmeci Journal: Hepatol Int Date: 2015-05-05 Impact factor: 9.029